Quantcast

Latest Graft-versus-host disease Stories

2013-08-08 11:00:32

Researchers from Indiana University, the University of Michigan, the Fred Hutchinson Cancer Research Center and the Dana-Farber Cancer Institute have identified and validated a biomarker accessible in blood tests that could be used to predict which stem cell transplant patients are at highest risk for a potentially fatal immune response called graft-versus-host disease. Although transplant specialists have been able to reduce its impact, graft-versus-host disease remains a leading cause of...

2013-08-07 10:19:58

Novel treatment boosted selective immune attack on leukemia cells in post-transplant patients Patients with advanced chronic lymphocytic leukemia (CLL) often receive donor transplants that effectively "reboot" their own immune defenses, which then attack and potentially cure the hard-to-treat disease. However, there is a high rate of relapse in these patients, and the transplanted immune cells may also harm normal tissues, causing graft-versus-host disease (GVHD). Now, scientists at...

2013-05-30 13:43:03

Stem Cell Matrix -- a summary of recent studies from HSCI May brought a major advancement in the science of aging when two Harvard Stem Cell Institute (HSCI) researchers announced their discovery of a protein circulating in the blood of mice and humans that shows potential to be a treatment for age-related heart failure. The protein, called GDF-11, reduced the size and thickness of the heart walls when injected into old mice. There are hundreds of investigators in the HSCI network...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related